Financials

People

Activity

Company

Investment-firm

Financing round

General

About Company
M28 Capital is a healthcare sector fund that invests in biotechnology and pharmaceutical companies to generate shareholder value.

Industry

Sector :

Subsector :

founders

IPO status

Private

Description

Located in Stamford, Connecticut, M28 Capital is a healthcare sector fund managed by Veltro Argento. The fund focuses on investing in impactful companies within the biotechnology and pharmaceutical industry, aiming to generate investment returns from the ongoing biotechnology and human health revolution.
Similar Companies
1000
BB Biotech Ventures

BB Biotech Ventures

BB BIOTECH VENTURES is a healthcare-focused venture capital fund.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Biotechnology, Venture Capital, Health Care

Location

Zürich, Switzerland

count Of Investments

41

count Of Exists

6
Santo Holding

Santo Holding

Santo Holding is a Zurich-based investment firm funding biotech and healthcare companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Pharmaceuticals, Life Science, Venture Capital

Location

Zürich, Switzerland

count Of Investments

7

count Of Exists

1
Brandon Capital Partners

Brandon Capital Partners

Brandon Capital Partners is an Australian fund management business specializing in life science investments.

Sector

Closed End Investments

Subsector

Closed End Investments

Location

Dandenong Rd, Melbourne VIC, Australia

count Of Investments

60

count Of Exists

3
Great Point Partners

Great Point Partners

Great Point Partners invests in biotech, pharma, medtech, and healthcare service companies.

Sector

Closed End Investments

Subsector

Closed End Investments

Keywords

Financial Services, Health Care, Advice

Location

Greenwich, CT, USA

count Of Investments

49

count Of Exists

15

Financials

Investments
2
Date 
name 
Lead 
type 
Raised 
16.06.2021
Yes
$100M
Fractyl Health

Fractyl Health

Fractyl Health uses Revita DMR to rejuvenate the lining of the duodenum.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Lexington, MA, USA

total rounds

9

total raised

$310.19M
Adagio Therapeutics

Adagio Therapeutics

Adagio is a biopharmaceutical company focused on antibody-based solutions for infectious diseases with pandemic potential.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Therapeutics

Location

Waltham, MA, USA

total rounds

3

total raised

$466M
Co-Investors

People

Founders
1

Marc Elia

Marc Elia, Founder of M28 Capital.

Marc Elia

Activity

Recent News
0